Clinical and Experimental Immunology

Journal Title

  • Clinical and Experimental Immunology

ISSN

  • E 1365-2249 | P 0009-9104 | 1365-2249 | 0009-9104

Publisher

  • Blackwell Publishing Inc.
  • Wiley-Blackwell

Listed on(Coverage)

JCR1997-2019
SJR1999-2019
CiteScore2011-2019
SCI2010-2019
SCIE2010-2021
CC2016-2021
SCOPUS2017-2020
MEDLINE2016-2021
EMBASE2016-2020

Active

  • Active

    based on the information

    • SCOPUS:2020-10

Country

  • USA

Aime & Scopes

  • Clinical & Experimental Immunology is a top ranking, international journal publishing biologically significant studies that have clinical relevance. The Journal is focused on Translational Immunology and is amongst the foremost journals in this field, attracting high-quality papers from all parts of the world. Translation is viewed as a process of applying ideas, insights and discoveries generated through basic scientific studies to the treatment, prevention or diagnosis of human disease. Journal articles cover clinical studies in patients receiving immune-based therapies, in relation to autoimmunity, primary and secondary immunodeficiencies, complement disorders and allergies. The Journal also reports investigations on the pathogenesis of rheumatic, renal and endocrine disorders, as well as infectious diseases, malignancy and transplantation. Basic immunology studies that inform clinical practice or understanding of disease mechanisms are also welcomed, as are studies in non-human model systems and reports on the physiological mechanisms of immunity. In addition to research reports, the Journal publishes highly cited review, perspective and hypothesis articles. These are usually commissioned and published as Translational Mini-Review series, but suggestions to the Editor-in-Chief of topics for such series, or titles for one-off review articles are welcome. The Journal encourages submission of articles that represent position papers on the classification, diagnosis or treatment of immunological disease. Articles deemed to be of potentially high impact may be drawn to the attention of the Editorial Team for allocation to our Fast-Track category, enabling papers of immediate interest to reach their audience as quickly as possible.

Article List

1 - 0 out of 0 results.

1

BROWSE